(NOVN:SIX SWISS EXCHANGE AG)
David R. Epstein B.Sc., M.B.A.
Division Head of Novartis Pharmaceuticals and Member of Executive Committee, Novartis AG
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 6 different industries.|
As of Fiscal Year 2013
Mr. David R. Epstein, B.Sc., M.B.A. has been Division Head of Novartis Pharmaceuticals at Novartis AG since 2010. Mr. Epstein serves as President of Novartis at Novartis Pharma K.K. He has been Head of Global Pharmaceuticals Division at Novartis AG and Novartis Vaccines and Diagnostics, Inc. since February 1, 2010. Mr. Epstein serves as President and Chief Executive Officer of Oncology and Molecular Diagnostics of Novartis Institutes for Biomedical Research, Inc. He ...
Lichtstrasse 35Phone: 41 61 324 11 11
Basel, Basel-Stadt 4056
Board Members Memberships*
Former Independent Director, Member of Governance & Nominating Committee and Member of Research, Regulatory & Clinical Committee
Columbia Business School
Rutgers, The State University of New Jersey
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Alex Gorsky||Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee|
Johnson & Johnson
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Serge Weinberg||Chairman, Interim Chief Executive Officer, Chairman of Appointments & Governance Committee and Chairman of Strategy Committee|
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.1M||Compensation as of Fiscal Year 2013.|